COVID-19 and Antiphospholipid Antibodies: Time for a Reality Check?

Abstract Antiphospholipid antibodies (aPL) comprise a panel of autoantibodies that reflect a potential prothrombotic risk in several autoimmune conditions, most notably antiphospholipid (antibody) syndrome (APS). aPL can be divided into those that form part of the laboratory criteria for APS, namely...

Full description

Bibliographic Details

Published in:	Seminars in thrombosis and hemostasis Vol. 48; no. 1; pp. 072 - 092
Main Authors:	Favaloro, Emmanuel J., Henry, Brandon Michael, Lippi, Giuseppe
Format:	Journal Article
Language:	English
Published:	333 Seventh Avenue, 18th Floor, New York, NY 10001, USA Thieme Medical Publishers, Inc 01.02.2022
Subjects:	Antibodies, Anticardiolipin Antibodies, Antiphospholipid Antiphospholipid Syndrome COVID-19 Humans Prothrombin Review Article SARS-CoV-2 COVID-19 anticardiolipin antibodies thrombosis anti-β2-glycoprotein I antibodies microthrombosis lupus anticoagulant antiphospholipid antibodies
ISSN:	0094-6176, 1098-9064, 1098-9064
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!